Trial
NCT00887926
Study of IMC-EB10 in Participant With Leukemia
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Myeloid Leukemia
Intervention
IMC-EB10
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-22